Search companies

Live

Tuesday, 17 November 2026 · 583 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

Algorae Chair Adds Shares Through On-Market Trade

1AI: $0.009 +0.00% · MC: $18M

Algorae Pharmaceuticals chairman David Hainsworth acquired additional shares through an on-market trade held indirectly via Cathedral Estate, increasing that holding. The notice reports no change to his direct holdings or other disclosed interests.

Source announcements: 2026-11-17 12:13 to 2026-11-17 12:13 Sydney time
Story updated 2026-11-17 12:16 Sydney time
SourcesChange of Director's Interest Notice - DH
Comments